Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation, randomised, singleblind, placebo-controlled phase Ib/IIa clinical trial

1. Álvaro-Gracia, J.M.
2. Jover, J.A.
3. García-Vicuña, R.
4. Carreño, L.
5. Alonso, A.
6. Marsal, S.
7. Blanco, F.
8. Martínez-Taboada, V.M.
9. Taylor, P.
10. Martín-Martín, C.
11. DelaRosa, O.
12. Tagarro, I.
13. Díaz-González, F.